10. Long-term treatment for ACS (Arabic Version)
1.4 هزار بار بازدید -
5 ماه پیش
-
How can you formulate a
How can you formulate a long-term plan for an ACS patient before hospital discharge & during follow-up at the OPD?
0:00 Intro
1:59 Cardiac Rehabilitation
3:36 Lifestyle Management
11:19 Pharmacotherapy
24:49 Adherence & Persistence
29:48 Imaging
30:32 Vaccination
31:26 Patient Perspectives
37:00 Finale
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
www.escardio.org/Guidelines/Clinical-Practice-Guid…
2023 ESC Guidelines for the management of acute coronary syndromes Supplementary data
oup.silverchair-cdn.com/oup/backfile/Content_publi…
2021 ESC Guidelines of CVD Prevention
www.escardio.org/Guidelines/Clinical-Practice-Guid…
Playlist for the videos of 2021 ESC Guidelines of CVD Prevention (Arabic Version)
• Preamble to CVD Prevention Guidelines...
Playlist for the videos of 2021 ESC Guidelines of CVD Prevention (English Version)
• Preamble to CVD Prevention Guidelines...
2019 ESC Guidelines of Management of Chronic Coronary Syndromes
www.escardio.org/Guidelines/Clinical-Practice-Guid…
IMPROVE-IT trial. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
www.nejm.org/doi/full/10.1056/NEJMoa1410489
ODYSSEY OUTCOMES trial. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
www.nejm.org/doi/full/10.1056/NEJMoa1801174
REMINDER trial. Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure
pubmed.ncbi.nlm.nih.gov/24780614/
EPHESUS trial. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
www.nejm.org/doi/full/10.1056/NEJMoa030207
PARADISE-MI trial. Prospective ARNI versus ACE Inhibitor Trial to Determine Superiority in Reducing Heart Failure Events After MI.
www.acc.org/Latest-in-Cardiology/Clinical-Trials/2…
EMPAREG-OUTCOME trial. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
pubmed.ncbi.nlm.nih.gov/26378978/
CANVAS trial. Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
www.nejm.org/doi/full/10.1056/NEJMoa1611925
DECLARE–TIMI 58. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
www.nejm.org/doi/full/10.1056/NEJMoa1812389
EMMY trial. Empagliflozin in acute myocardial infarction.
academic.oup.com/eurheartj/article/43/41/4421/6677…
SECURE trial. Polypill Strategy in Secondary Cardiovascular Prevention
www.nejm.org/doi/full/10.1056/NEJMoa2208275
5 ماه پیش
در تاریخ 1403/02/01 منتشر شده
است.
1,421
بـار بازدید شده